Handelsbanken Fonder Portfolio holdings
AUM
$28.2B
1-Year Return
24.55%
This Quarter Return
+4.4%
1 Year Return
+24.55%
3 Year Return
+103.92%
5 Year Return
+192.89%
10 Year Return
–
AUM
$3.27B
AUM Growth
-$145M
(-4.2%)
Cap. Flow
-$185M
Cap. Flow
% of AUM
-5.66%
Top 10 Holdings %
Top 10 Hldgs %
25.06%
Holding
179
New
14
Increased
49
Reduced
71
Closed
21
Top Buys
| 1 |
UnitedHealth
UNH
|
$53.9M |
| 2 |
SBNY
Signature Bank
SBNY
|
$37.3M |
| 3 |
East-West Bancorp
EWBC
|
$23.9M |
| 4 |
TSMC
TSM
|
$17.4M |
| 5 |
NVIDIA
NVDA
|
$16.1M |
Top Sells
| 1 |
Ecolab
ECL
|
$24.7M |
| 2 |
AGN
Allergan plc
AGN
|
$22.3M |
| 3 |
Wells Fargo
WFC
|
$22.1M |
| 4 |
W.W. Grainger
GWW
|
$20.3M |
| 5 |
PRA Group
PRAA
|
$19.6M |
Sector Composition
| 1 | Consumer Discretionary | 16.06% |
| 2 | Healthcare | 15.47% |
| 3 | Financials | 15.03% |
| 4 | Communication Services | 14.24% |
| 5 | Technology | 13.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WRK
101
DELISTED
WestRock Company
WRK
| $7.62M | 0.23% |
150,000
-20,000
| -12% | -$1.02M |
|
|
102
Ecolab
ECL
$77.9B
| $7.03M | 0.22% |
60,000
-210,365
| -78% | -$24.7M |
|
103
Bristol-Myers Squibb
BMY
$95.1B
| $6.75M | 0.21% |
115,560
-25,000
| -18% | -$1.46M |
|
104
Exelixis
EXEL
$10.1B
| $6.71M | 0.21% |
450,000
+85,000
| +23% | +$1.27M |
|
105
Exponent
EXPO
$3.66B
| $6.69M | 0.2% |
222,000
-178,000
| -45% | -$5.37M |
|
106
Wolverine World Wide
WWW
$2.61B
| $6.59M | 0.2% |
300,000
-125,000
| -29% | -$2.74M |
|
|
AGN
107
DELISTED
Allergan plc
AGN
| $6.04M | 0.18% |
28,744
-106,000
| -79% | -$22.3M |
|
108
Estee Lauder
EL
$32.2B
| $5.74M | 0.18% |
75,000
-10,000
| -12% | -$765K |
|
109
Itaú Unibanco
ITUB
$76.5B
| $4.88M | 0.15% |
950,973
-2
| -0% | -$10 |
|
|
PFPT
110
DELISTED
Proofpoint, Inc.
PFPT
| $4.75M | 0.15% |
67,200
+23,000
| +52% | +$1.63M |
|
111
Fomento Económico Mexicano
FMX
$29.7B
| $4.71M | 0.14% |
61,820
-27,500
| -31% | -$2.1M |
|
112
Expedia Group
EXPE
$26.5B
| $4.53M | 0.14% |
40,000
-20,000
| -33% | -$2.27M |
|
|
ALXN
113
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $4.45M | 0.14% |
36,400
-3,000
| -8% | -$367K |
|
114
Electronic Arts
EA
$41.9B
| $4.33M | 0.13% |
55,000
-20,000
| -27% | -$1.58M |
|
115
Glaukos
GKOS
$5.35B
| $4.29M | 0.13% |
125,000
| – | – |
|
116
FibroGen
FGEN
$46.1M
| $4.26M | 0.13% |
7,960
| – | – |
|
117
TAL Education Group
TAL
$6.21B
| $4.21M | 0.13% |
360,000
+60,000
| +20% | +$702K |
|
|
TSRO
118
DELISTED
TESARO, Inc.
TSRO
| $3.9M | 0.12% |
29,000
+14,000
| +93% | +$1.88M |
|
119
Neurocrine Biosciences
NBIX
$14.4B
| $3.87M | 0.12% |
100,000
| – | – |
|
|
MON
120
DELISTED
Monsanto Co
MON
| $3.68M | 0.11% |
35,000
| – | – |
|
121
Acadia Pharmaceuticals
ACAD
$4.27B
| $3.46M | 0.11% |
+120,000
| New | +$3.46M |
|
|
NBIS
122
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.3B
| $3.42M | 0.1% |
170,000
-19,000
| -10% | -$382K |
|
123
Galicia Financial Group
GGAL
$6.26B
| $3.35M | 0.1% |
124,500
| – | – |
|
124
Merck
MRK
$211B
| $3.3M | 0.1% |
58,688
+47,160
| +409% | +$2.65M |
|
|
BETR
125
DELISTED
Amplify Snack Brands, Inc.
BETR
| $3.08M | 0.09% |
350,000
+50,000
| +17% | +$441K |
|